A Single Arm Pilot Study of Intrathecally Administered DepoCyt With Systemic Sorafenib in the Treatment of Neoplastic Meningitis From Solid Tumors.

Trial Profile

A Single Arm Pilot Study of Intrathecally Administered DepoCyt With Systemic Sorafenib in the Treatment of Neoplastic Meningitis From Solid Tumors.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 27 Mar 2012

At a glance

  • Drugs Cytarabine; Sorafenib
  • Indications Neoplastic meningitis
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Aug 2011 Planned end date changed from 1 Sep 2016 to 1 Feb 2011 as reported by ClinicalTrials.gov.
    • 09 Aug 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 18 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top